The 10-second takeaway
For the quarter ended Sep. 30 (Q3), Ameren missed estimates on revenues and missed estimates on earnings per share.
Compared to the prior-year quarter, revenue contracted and GAAP earnings per share grew significantly.
Margins grew across the board.
Ameren tallied revenue of $2.00 billion. The two analysts polled by S&P Capital IQ hoped for sales of $2.14 billion on the same basis. GAAP reported sales were 9.5% lower than the prior-year quarter's $2.21 billion.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $1.33. The nine earnings estimates compiled by S&P Capital IQ averaged $1.40 per share. GAAP EPS of $1.54 for Q3 were 31% higher than the prior-year quarter's $1.18 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 47.1%, 230 basis points better than the prior-year quarter. Operating margin was 31.7%, 120 basis points better than the prior-year quarter. Net margin was 18.7%, 580 basis points better than the prior-year quarter.
Next quarter's average estimate for revenue is $1.94 billion. On the bottom line, the average EPS estimate is $0.16.
Next year's average estimate for revenue is $7.37 billion. The average EPS estimate is $2.44.
The stock has a two-star rating (out of five) at Motley Fool CAPS, with 189 members out of 233 rating the stock outperform, and 44 members rating it underperform. Among 66 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 57 give Ameren a green thumbs-up, and nine give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Ameren is hold, with an average price target of $31.83.
Can your retirement portfolio provide you with enough income to last? You'll need more than Ameren. Learn about crafting a smarter retirement plan in "The Shocking Can't-Miss Truth About Your Retirement." Click here for instant access to this free report.
- Add Ameren to My Watchlist.